Mystic Pharmaceuticals


Developer of non‑invasive drug and biologic delivery device platforms and unit‑dose primary container systems for ophthalmic, intranasal (systemic), nose‑to‑brain, sublingual/buccal, otic and animal care applications. Provides device design, unit‑dose blister packaging, analytical characterization, fill/finish engineering, preclinical/clinical supply support and commercial scale‑up services for pharmaceutical, biotech and public‑health countermeasure applications.

Industries

pharmaceutical

Nr. of Employees

small (1-50)

Mystic Pharmaceuticals

Austin, Texas, United States, North America


Products

Platform for liquid delivery and unit‑dose blister packaging

Integrated liquid delivery platform composed of unit‑dose blisters with embedded micro‑nozzles and matching handheld dispensers, configurable for ophthalmic, intranasal, nose‑to‑brain, sublingual and animal care applications.

Platform for powder delivery and reconstitution

Integrated powder delivery platform supporting dry powder, reconstituted powder‑to‑liquid and liquid/liquid recombination applications with active powder aerosolization and unit‑dose blister packaging.


Services

Analytical characterization and testing services

Dispense characterization (laser diffraction), plume morphology (high‑speed video), aerodynamic deposition testing (cascade impactor and nasal cast), delivered dose uniformity/consistency, emitted dose (shot weight), size‑exclusion chromatography, device force to actuate, and fluidic properties analysis.

Pre‑commercial technical services and prototyping

Prototype configuration and supply, primary container/dispenser configuration and optimization, analytical testing, process engineering for fill operations, preclinical and clinical supply support, and regulatory documentation (DMF).

Commercialization and manufacturing services

Commercial technology transfer, commercial scale‑up, commercial supply through partners, capital equipment supply and siting, and technology licensing.

Expertise Areas

  • Non‑invasive drug delivery device development
  • Unit‑dose blister packaging and primary container materials
  • Fill/finish manufacturing and commercial scale‑up
  • Analytical characterization of aerosols and sprays
  • Show More (4)

Key Technologies

  • Form‑Fill‑Seal (FFS) unit‑dose blister manufacturing
  • Multi‑layer laminate primary containers with high barrier properties
  • Micro‑molded medical‑grade polymer micro‑nozzles
  • Laser diffraction droplet/particle sizing
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.